Article
The changing mutational landscape of acute myeloid leukemia and myelodysplastic syndrome.
Molecular cancer research : MCR - 1 Aug 2013
Larsson Connie A, Cote Gilbert, Quintás-Cardama Alfonso
Abstract excerpt
UNLABELLED: Over the past few years, large-scale genomic studies of patients with myelodysplastic syndrome (MDS) and acute myelogenous leukemia (AML) have unveiled recurrent somatic mutations in genes involved in epigenetic regulation (DNMT3A, IDH1/2, TET2, ASXL1, EZH2 and MLL) and the spliceosomal machinery (SF3B1, U2AF1, SRSF2, ZRSR2, SF3A1, PRPF40B, U2AF2, and SF1). The identification of these mutations and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
